NBI-5788

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBI-5788, covering 2008-03-21 to 2008-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS) [Phase 2]